Dan Greenberg

Summary

Affiliation: Ben-Gurion University of the Negev
Country: Israel

Publications

  1. doi Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions?
    Dan Greenberg
    The Center for the Evaluation of Value and Risk in Health, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
    Expert Rev Pharmacoecon Outcomes Res 11:113-9. 2011
  2. pmc Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    Don Husereau
    Institute of Health Economics, Edmonton, Canada
    Cost Eff Resour Alloc 11:6. 2013
  3. pmc Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    Don Husereau
    Institute of Health Economics, Edmonton, Canada
    BMC Med 11:80. 2013
  4. doi Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventions
    Dan Greenberg
    Department of Health Systems Management, Faculty of Health Sciences, and the Guilford Glazer Faculty of Business and Management, Ben Gurion University of the Negev, Beer Sheva, Israel
    Value Health 16:842-7. 2013
  5. doi Peer review in publication: factors associated with the full-length publication of studies presented in abstract form at the annual meeting of the Society for Medical Decision Making
    Dan Greenberg
    Department of Health Systems Management, Ben Gurion University of the Negev, Beer Sheva, Israel
    Med Decis Making 28:938-42. 2008
  6. doi The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair?
    Dan Greenberg
    Department of Health Systems Management, Ben Gurion University of the Negev, PO Box 653, Beer Sheva 84105, Israel
    Int J Technol Assess Health Care 25:255-61. 2009
  7. doi A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006
    Dan Greenberg
    Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA
    Med Decis Making 30:320-7. 2010
  8. ncbi Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers
    Dan Greenberg
    Department of Health System Management, Ben Gurion University of the Negev, Beer Sheva, Israel
    Int J Technol Assess Health Care 21:219-27. 2005
  9. ncbi Growth and quality of the cost-utility literature, 1976-2001
    Peter J Neumann
    Program on the Economic Evaluation of Medical Technology, Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
    Value Health 8:3-9. 2005
  10. ncbi Can we better prioritize resources for cost-utility research?
    Peter J Neumann
    Harvard School of Public Health, Boston, MA 02115, USA
    Med Decis Making 25:429-36. 2005

Detail Information

Publications37

  1. doi Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions?
    Dan Greenberg
    The Center for the Evaluation of Value and Risk in Health, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
    Expert Rev Pharmacoecon Outcomes Res 11:113-9. 2011
    ..We investigated the extent to which adjusting for health-related quality of life (HRQoL) alters incremental cost per life-year gained ratios, and the implications for reimbursement decisions...
  2. pmc Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    Don Husereau
    Institute of Health Economics, Edmonton, Canada
    Cost Eff Resour Alloc 11:6. 2013
    ..We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years...
  3. pmc Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
    Don Husereau
    Institute of Health Economics, Edmonton, Canada
    BMC Med 11:80. 2013
    ..We encourage other journals and groups, to endorse CHEERS. The author team plans to review the checklist for an update in five years...
  4. doi Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventions
    Dan Greenberg
    Department of Health Systems Management, Faculty of Health Sciences, and the Guilford Glazer Faculty of Business and Management, Ben Gurion University of the Negev, Beer Sheva, Israel
    Value Health 16:842-7. 2013
    ..We determined how Israeli oncologists and family physicians value life-prolongation versus quality-of-life (QOL)-enhancing outcomes attributable to cancer and congestive heart failure interventions...
  5. doi Peer review in publication: factors associated with the full-length publication of studies presented in abstract form at the annual meeting of the Society for Medical Decision Making
    Dan Greenberg
    Department of Health Systems Management, Ben Gurion University of the Negev, Beer Sheva, Israel
    Med Decis Making 28:938-42. 2008
    ..Many studies are presented at scientific meetings and are summarized in abstract form prior to their full-length publication. Publication rates of these studies may be an indicator in judging their quality...
  6. doi The process of updating the National List of Health Services in Israel: is it legitimate? Is it fair?
    Dan Greenberg
    Department of Health Systems Management, Ben Gurion University of the Negev, PO Box 653, Beer Sheva 84105, Israel
    Int J Technol Assess Health Care 25:255-61. 2009
    ..Although this process has been described in detail in previous papers, none of these have fully addressed legitimacy and fairness. We examine the legitimacy and fairness of the process of updating the NLHS in Israel...
  7. doi A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006
    Dan Greenberg
    Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA
    Med Decis Making 30:320-7. 2010
    ..Despite the proliferation of CEA research, there has been no detailed study focusing on the bibliometric properties of this literature...
  8. ncbi Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers
    Dan Greenberg
    Department of Health System Management, Ben Gurion University of the Negev, Beer Sheva, Israel
    Int J Technol Assess Health Care 21:219-27. 2005
    ....
  9. ncbi Growth and quality of the cost-utility literature, 1976-2001
    Peter J Neumann
    Program on the Economic Evaluation of Medical Technology, Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
    Value Health 8:3-9. 2005
    ..This study updates and expands our previous work, which examined CUAs through 1997...
  10. ncbi Can we better prioritize resources for cost-utility research?
    Peter J Neumann
    Harvard School of Public Health, Boston, MA 02115, USA
    Med Decis Making 25:429-36. 2005
    ....
  11. ncbi Trends in the measurement of health utilities in published cost-utility analyses
    Carmen A Brauer
    Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, MA, USA
    Value Health 9:213-8. 2006
    ..tufts-nemc.org/cearegistry; previously at http://www.hsph.harvard.edu/cearegistry), and documents recent changes in methods used for utility weight elicitation...
  12. pmc Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money?
    Hansel J Otero
    Department of Radiology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA 02111, USA
    Int J Cardiovasc Imaging 26:605-12. 2010
    ..The studies available have, in general, favorable cost-effectiveness profiles with major determinants relating to being compared against observation, medical or no intervention instead of other imaging tests...
  13. ncbi Can we afford to eliminate restenosis? Can we afford not to?
    Dan Greenberg
    Harvard Clinical Research Institute, Boston, Massachusetts, USA
    J Am Coll Cardiol 43:513-8. 2004
    ....
  14. doi The adoption of cost-effectiveness acceptability curves in cost-utility analyses
    Lisa M Meckley
    Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Med Decis Making 30:314-9. 2010
    ..g., life-years or quality-adjusted life-years gained)...
  15. ncbi Decision making in acquiring medical technologies in Israeli medical centers: a preliminary study
    Dan Greenberg
    Ben Gurion University of the Negev, Beer Sheva, Israel
    Int J Technol Assess Health Care 19:194-201. 2003
    ....
  16. doi Financial risk-sharing in updating the National List of Health Services in Israel: stakeholders' perceived interests
    Ariel Hammerman
    Department of Health Systems Management, Faculty of Health Sciences and Guilford Glazer Faculty of Business and Management, Ben Gurion University of Negev, Beer Sheva, Israel
    Value Health 15:737-42. 2012
    ....
  17. ncbi Do drug formulary policies reflect evidence of value?
    Peter J Neumann
    Department of Health Policy and Management and Center for Risk Analysis, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Manag Care 12:30-6. 2006
    ..To investigate the extent to which preferred drug lists and tiered formularies reflect evidence of value, as measured in published cost-utility analyses (CUAs)...
  18. doi Does framing of cancer survival affect perceived value of care? A willingness-to-pay survey of US residents
    Pei Jung Lin
    Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
    Expert Rev Pharmacoecon Outcomes Res 13:513-22. 2013
    ..To investigate the relationship between the framing of survival gains and the perceived value of cancer care...
  19. doi Estimating the budget impact of new technologies added to the National List of Health Services in Israel: stakeholders' incentives for adopting a financial risk-sharing mechanism
    Ariel Hammerman
    Department of Health Systems Management, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Health Policy 89:78-83. 2009
    ..We provide a framework for a financial risk-sharing mechanism between HMOs and the industry, which may be able to balance these incentives and result in more accurate early budget-impact estimates...
  20. ncbi When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature
    Daniel Talmor
    Department of Anesthesia, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Crit Care Med 34:2738-47. 2006
    ..Cost-effectiveness analyses (CEAs) have become increasingly common to aid decisions about the allocation of scarce healthcare resources...
  21. ncbi Low-value services in value-based insurance design
    Peter J Neumann
    Center for the Evaluation of Value and Risk in Health, Tufts Medical Center, Boston, MA 02111, USA
    Am J Manag Care 16:280-6. 2010
    ..To identify potentially low-value services for inclusion in value-based insurance design (VBID) programs and to discuss challenges involved in incorporating such information...
  22. doi Cost-utility analyses of diagnostic laboratory tests: a systematic review
    Chihui Fang
    Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
    Value Health 14:1010-8. 2011
    ..To review and evaluate the literature of cost-utility analyses (CUAs) regarding diagnostic laboratory testing...
  23. ncbi Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study
    Dan Greenberg
    Harvard Clinical Research Institute, Boston, MA, USA
    Health Policy 70:207-16. 2004
    ..The contingent valuation approach may offer particular advantages when evaluating treatments that improve short-term health outcomes...
  24. ncbi [Can linking co-payment for drugs to evidence on treatment value improve health outcomes and contain healthcare costs?]
    Noa Triki
    Department of Health Systems Management, Ben Gurion University of the Negev
    Harefuah 149:524-8, 550. 2010
    ..Further research is needed to examine the feasibility of this approach and the long-term impact on quality of care and treatment costs in other healthcare systems, including Israel...
  25. pmc Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis
    Dan Greenberg
    Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
    BMJ 328:1536-7. 2004
  26. doi The costs and cost-effectiveness of an integrated sepsis treatment protocol
    Daniel Talmor
    Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA, USA
    Crit Care Med 36:1168-74. 2008
    ..Sepsis is associated with high mortality and treatment costs. International guidelines recommend the implementation of integrated sepsis protocols; however, the true cost and cost-effectiveness of these are unknown...
  27. pmc When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology
    Dan Greenberg
    Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA 02111, USA
    J Natl Cancer Inst 102:82-8. 2010
    ..Because we found only modest improvement in the quality of studies, we suggest that journals provide specific guidance for reporting CUA and assure that authors adhere to guidelines for conducting and reporting economic evaluations...
  28. ncbi Laparoscopic versus open appendectomy: results of a retrospective comparison in an Israeli hospital
    Jochanan G Peiser
    Soroka University Medical Center, Department of Health Policy and Management, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Isr Med Assoc J 4:91-4. 2002
    ..Recently, several authors proposed that the new technique of laparoscopic appendectomy should be the preferred treatment for acute appendicitis. However, unlike laparoscopic cholecystectomy, LA has not yet gained popularity...
  29. ncbi [Risk-sharing schemes: a new paradigm in adopting innovative pharmaceuticals]
    Ariel Hammerman
    Department of Health Systems Management, Ben Gurion University of the Negev, Beer Sheva
    Harefuah 151:364-7, 376. 2012
    ..This article reviews the principles of risk-sharing schemes and issues involved in the actual implementation of such agreements...
  30. doi Much cheaper, almost as good: decrementally cost-effective medical innovation
    Aaron L Nelson
    Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Tufts University School of Medicine, Boston, Massachusetts, USA
    Ann Intern Med 151:662-7. 2009
    ..001 to 0.021 quality-adjusted life-years (approximately 8 hours to 1 week). These findings demonstrate the rarity of decrementally cost-effective innovations in the medical literature...
  31. ncbi In-hospital costs of self-expanding nitinol stent implantation versus balloon angioplasty in the femoropopliteal artery (the VascuCoil Trial)
    Dan Greenberg
    Cardiovascular Division, Beth Israel Deaconess Medical Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Vasc Interv Radiol 15:1065-9. 2004
    ....
  32. ncbi [Public financing for off-label use of drugs]
    Ariel Hammerman
    Department of Health Systems Management, Ben Gurion University of the Negev, Beer Sheba
    Harefuah 150:163-7, 204. 2011
    ..We also provide a brief summary of off-label policies in a few western countries...
  33. ncbi Implantable cardioverter defibrillators in Israel: utilization and implantation trends
    Dan Greenberg
    Department of Health Policy and Management, Ben Gurion University of the Negev, Beer Sheva 84105, Israel
    Int J Cardiol 82:17-23. 2002
    ..The main objectives of this study were to analyze the Israeli experience with ICD implantation from 1993 to 1999, to examine the diffusion of ICD therapy in Israel and the evolution of implantation patterns and indications...
  34. pmc Twenty years of cost-effectiveness analysis in medical imaging: are we improving?
    Hansel J Otero
    Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA
    Radiology 249:917-25. 2008
    ..S. Panel on Cost-effectiveness in Health and Medicine recommendations affected CEA studies in which imaging technologies were evaluated...
  35. ncbi Examining the economic impact of restenosis: implications for the cost-effectiveness of an antiproliferative stent
    Dan Greenberg
    Cardiovascular Division, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA
    Z Kardiol 91:137-43. 2002
    ..S. healthcare system...
  36. doi Is the United States ready for QALYs?
    Peter J Neumann
    Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA
    Health Aff (Millwood) 28:1366-71. 2009
    ..S. health care system. Strict adherence to a QALY approach is likely to prove unacceptable in the United States, but a more flexible use of QALYs could be beneficial...
  37. doi Nutritional risk and health care use before and after an acute hospitalization among the elderly
    Ilana Feldblum
    The S Daniel Abraham International Center for Health and Nutrition, Ben Gurion University, Beer Sheva, Israel
    Nutrition 25:415-20. 2009
    ..Our objective was to assess the nutritional status and health care use of community-dwelling elderly before hospitalization and determine risk factors for longer hospitalizations during 3 mo of follow-up...